D. E. Shaw & Co., Inc. Bluebird Bio, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $344,400 - $437,500	10,000 Added 35.46%	38,200 $2.06 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $4.21 Million - $10.2 Million	-160,900 Reduced 85.09%	28,200 $1.3 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $1.15 Million - $1.5 Million	24,400 Added 14.81%	189,100 $16.6 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $172,463 - $269,990	-2,900 Reduced 1.73%	164,700 $15.1 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $219,936 - $305,109	2,900 Added 1.76%	167,600 $21.3 Million
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $2.04 Million - $3.3 Million	-31,700 Reduced 16.14%	164,700 $25.9 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $1.55 Million - $2.45 Million	26,300 Added 15.46%	196,400 $19.5 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $3.55 Million - $4.7 Million	40,000 Added 30.75%	170,100 $24.8 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $3.72 Million - $4.76 Million	37,300 Added 40.19%	130,100 $20.4 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $4.18 Million - $5.96 Million	39,500 Added 74.11%	92,800 $15.8 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $1.22 Million - $1.96 Million	15,000 Added 39.16%	53,300 $9.49 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $2.21 Million - $3.5 Million	38,300	38,300 $5.26 Million

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $696M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.